Anisotropic biodegradable lipid coated particles for spatially dynamic protein presentation

Acta Biomater. 2018 May:72:228-238. doi: 10.1016/j.actbio.2018.03.056. Epub 2018 Apr 7.

Abstract

There has been growing interest in the use of particles coated with lipids for applications ranging from drug delivery, gene delivery, and diagnostic imaging to immunoengineering. To date, almost all particles with lipid coatings have been spherical despite emerging evidence that non-spherical shapes can provide important advantages including reduced non-specific elimination and increased target-specific binding. We combine control of core particle geometry with control of particle surface functionality by developing anisotropic, biodegradable ellipsoidal particles with lipid coatings. We demonstrate that these lipid coated ellipsoidal particles maintain advantageous properties of lipid polymer hybrid particles, such as the ability for modular protein conjugation to the particle surface using versatile bioorthogonal ligation reactions. In addition, they exhibit biomimetic membrane fluidity and demonstrate lateral diffusive properties characteristic of natural membrane proteins. These ellipsoidal particles simultaneously provide benefits of non-spherical particles in terms of stability and resistance to non-specific phagocytosis by macrophages as well as enhanced targeted binding. These biomaterials provide a novel and flexible platform for numerous biomedical applications.

Statement of significance: The research reported here documents the ability of non-spherical polymeric particles to be coated with lipids to form anisotropic biomimetic particles. In addition, we demonstrate that these lipid-coated biodegradable polymeric particles can be conjugated to a wide variety of biological molecules in a "click-like" fashion. This is of interest due to the multiple types of cellular mimicry enabled by this biomaterial based technology. These features include mimicry of the highly anisotropic shape exhibited by cells, surface presentation of membrane bound protein mimetics, and lateral diffusivity of membrane bound substrates comparable to that of a plasma membrane. This platform is demonstrated to facilitate targeted cell binding while being resistant to non-specific cellular uptake. Such a platform could allow for investigations into how physical parameters of a particle and its surface affect the interface between biomaterials and cells, as well as provide biomimetic technology platforms for drug delivery and cellular engineering.

Keywords: Biomimetic; Lipids; Membrane fluidity; Particle shape; Polymers.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anisotropy
  • Coated Materials, Biocompatible* / chemistry
  • Coated Materials, Biocompatible* / pharmacokinetics
  • Coated Materials, Biocompatible* / pharmacology
  • Lipids* / chemistry
  • Lipids* / pharmacokinetics
  • Lipids* / pharmacology
  • Macrophages / cytology
  • Macrophages / metabolism*
  • Membranes, Artificial*
  • Mice
  • Phagocytosis / drug effects*
  • Proteins* / chemistry
  • Proteins* / pharmacokinetics
  • Proteins* / pharmacology
  • RAW 264.7 Cells

Substances

  • Coated Materials, Biocompatible
  • Lipids
  • Membranes, Artificial
  • Proteins